Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Ocata Therapeutics, Inc. | actc_10q-ex3101.htm |
| EX-10.1 - SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT - Ocata Therapeutics, Inc. | actc_10q-ex1001.htm |
| EX-31.2 - CERTIFICATION - Ocata Therapeutics, Inc. | actc_10q-ex3102.htm |
| EX-32.2 - CERTIFICATION - Ocata Therapeutics, Inc. | actc_10q-ex3202.htm |
| EX-10.2 - EMPLOYMENT AGREEMENT - Ocata Therapeutics, Inc. | actc_10q-ex1002.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Ocata Therapeutics, Inc. | Financial_Report.xls |
| 10-Q - QUARTERLY REPORT - Ocata Therapeutics, Inc. | actc_10q-093014.htm |
EXHIBIT 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER
AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Paul Wotten, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Advanced Cell Technology, Inc. for the quarter ended September 30, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Advanced Cell Technology, Inc.
| Dated: November 10, 2014 | By: | /s/ Paul Wotton |
| Paul Wotton | ||
| President and Chief Executive Officer (Principal Executive Officer) |